Independent Research, SPACs, SPAC Track

SPAC Track

Independent Research, SPACs

Equity Capital Markets

<ul><li>Social Capital Suvretta Holdings Corp. III (DNAC: no warrants, common +0.01%) &amp; ProKidney</li><li>Vishal Garg, founder and CEO of digital mortgage lender Better, [merging with Aurora Acquisition Corp. (AURC)] is staying on as CEO</li><li>Shares of SoFi rallied as more than 16% in after-hours trading on Tuesday following news that the fintech cleared its final regulatory hurdle in becoming a bank.</li></ul>

Social Capital Suvretta Holdings Corp. III (DNAC: no warrants, common +0.01%) &amp; ProKidneyVishal Garg, founder and CEO of digital mortgage lender Better, [merging with Aurora Acquisition Corp. (AURC)] is staying on as CEOShares of SoFi rallied as more than 16% in after-hours trading on Tuesday following news that the fintech cleared its final regulatory hurdle in becoming a bank.

SPAC Deep Dive, subSPAC

subSPAC

SPAC Deep Dive

Each week we’ll identify and break down for you SPACs that are capturing market share and making an impact.

Gores Holdings IX / Equity Capital Markets

<ul>
<li>While a majority of SPAC dealmakers have faced issues such as raising adequate financing for deals or acquiring high-quality merger targets, Serial SPAC Sponsors appear to have emerged relatively unscathed.</li>
<li>Serial Sponsors such as Gores, Palihapitiya, Cohen and Klein delivered the biggest deals of the industry</li>
<li>With 2022 being billed as the year of consolidation in SPACs, these sponsors have the potential to make or break the industry.</li>
</ul>


While a majority of SPAC dealmakers have faced issues such as raising adequate financing for deals or acquiring high-quality merger targets, Serial SPAC Sponsors appear to have emerged relatively unscathed.
Serial Sponsors such as Gores, Palihapitiya, Cohen and Klein delivered the biggest deals of the industry
With 2022 being billed as the year of consolidation in SPACs, these sponsors have the potential to make or break the industry.


These Dealmakers will Make or Break SPACs in 2022

<ul><li>Exactly one year to the day after Chamath Palihapitiya’s last SPAC deal announcement, we have news that one of his four biotech SPACs is in talks with a kidney restoration company.</li><li>Carousell Pte, a Singapore-based online classifieds marketplace operator, is in talks to go public through a merger with blank-check company L Catterton Asia Acquisition Corp</li><li>Virgin Group is drawing up detailed plans to list a new special purpose acquisition company (SPAC) in Amsterdam in the coming months</li></ul>

Exactly one year to the day after Chamath Palihapitiya’s last SPAC deal announcement, we have news that one of his four biotech SPACs is in talks with a kidney restoration company.Carousell Pte, a Singapore-based online classifieds marketplace operator, is in talks to go public through a merger with blank-check company L Catterton Asia Acquisition CorpVirgin Group is drawing up detailed plans to list a new special purpose acquisition company (SPAC) in Amsterdam in the coming months

United States

ProKidney Corp operates as a biotech company. The Company develops therapies that repairs and restores diseased kidneys using a patient's own cells and may prevent or delay dialysis or transplant. ProKidney serves customers worldwide.

ProKidney (PROK US)

The Nightcap from SPAC Track

Social Capital Suvretta Holdings Corp. III (DNAC: no warrants, common +0.01%) & ProKidney. Vishal Garg, founder and CEO of digital mortgage lender...

SPAC Track

These Dealmakers will Make or Break SPACs in 2022

While a majority of SPAC dealmakers have faced issues such as raising adequate financing for deals or acquiring high-quality merger targets, Serial...

subSPAC

The Nightcap from SPAC Track

Exactly one year to the day after Chamath Palihapitiya’s last SPAC deal announcement, we have news that one of his four biotech SPACs is in talks...

SPAC Track